InsidersTradesSigma
Track the 百克生物 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 百克生物 has published 4 reports. Market capitalisation: €6bn. The latest transaction was disclosed on 27 February 2024 (Sale). Among the most active insiders: 朱昌林. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
百克生物是一家专注于医疗保健和制药领域的公司，专门开发生物制药解决方案。该公司在上海证券交易所 (XSHG) 上市。